
Low-Cost Drugs Still Relevant in the Present-Day Era
Author(s) -
S. R. Daga
Publication year - 2021
Publication title -
european journal of clinical medicine
Language(s) - English
Resource type - Journals
ISSN - 2736-5476
DOI - 10.24018/clinicmed.2021.2.6.134
Subject(s) - theophylline , poverty , business , medicine , population , drug , intensive care medicine , pharmacology , environmental health , economic growth , economics
Escalating medical costs contribute to poverty in countries with low resources. The drug costs account for 17 percent of medical expenses. Revisiting time-tested, cost-effective drugs can reduce these costs. Some of them find a place in the WHO Model List of Essential Medicines for Children. The list consists of medicines for a basic healthcare system. They are safe and cost-effective. The present paper identifies co-trimoxazole and chloramphenicol as antimicrobials, chloroquine for malaria, adrenaline, theophylline for asthma, and phenobarbital as an anti-epileptic drug that merits consideration for reviving interest in them and reduce drug treatment costs.
What is already known about this subject?
• The cost of drugs contributes to rising medical costs.
• Medical expenses push a large population below the poverty line.
What does this study add?
• Rediscovering the relevance of old low-cost drugs is essential.
• Revisiting the WHO Model List of Essential Medicines for Children may be useful.
• Drugs such as chloramphenicol and theophylline are such examples.